WHY DO WE STILL NOT HAVE CARDIOPROTECTIVE DRUGS ON THE MARKET? IMPORTANCE OF RISK FACTORS AND UNBIASED WAYS TO IDENTIFY DRUG TARGETS. Issue 3 (September 2018)